Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells

Microcirculation : the Official Journal of the Microcirculatory Society, Inc
Michael J EppihimerJohn P Leonard

Abstract

To evaluate the expression and regulation of a novel B7-like protein, PD-L1, the ligand for the immunoinhibitory receptor PD-1 expressed on activated T-cells, on microvascular endothelial cells (ECs) PD-L1 expression on ECs in vitro and in vivo was quantified by using a dual radiolabeled antibody technique after treatment with interferons (IFN) and IL-12, respectively. Changes in the level of PD-L1 mRNA were determined by using RT-PCR. PD-L1 was observed to be present on ECs under basal conditions. Treatment of ECs with IFN-alpha, -beta and -gamma, but not LPS, was observed to induce elevations in the mRNA and surface expression of PD-L1 on ECs. By using a dual radiolabeled monoclonal antibody (mAb) technique, PD-L1 expression in various tissues of control and IL-12 challenged wild-type and IFN-gamma-deficient mice was measured. A significant increase in PD-L1 expression was observed in tissues at 24 hours after IL-12-challenge, with peak levels of PD-L1 occurring 72 hours after IL-12 challenge. IL-12 was not effective at inducing PD-L1 expression in tissues of IFN-gamma-deficient mice. These data show the expression of a novel B7-like molecule on murine ECs that is mediated by IFN-alpha, -beta, and -gamma, and suggest a potent...Continue Reading

Citations

Jul 9, 2003·The Journal of Experimental Medicine·Yoshiko IwaiTasuku Honjo
Jul 9, 2003·The Journal of Experimental Medicine·Mohammed Javeed I AnsariMohamed H Sayegh
Jul 9, 2003·The Journal of Experimental Medicine·Alan D SalamaSamia J Khoury
Aug 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xingxing ZangJames P Allison
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yvette E LatchmanArlene H Sharpe
Apr 12, 2006·The Journal of Experimental Medicine·Mary E KeirArlene H Sharpe
Sep 27, 2006·The Journal of Experimental Medicine·Gordon J FreemanArlene H Sharpe
Sep 15, 2007·The Journal of Clinical Investigation·Israel GotsmanAndrew H Lichtman
Nov 26, 2008·Circulation Research·Israel GotsmanAndrew H Lichtman
May 30, 2009·The Journal of Clinical Investigation·Christophe M FilippiMatthias G von Herrath
Jun 22, 2012·Journal of Transplantation·Marcos V SilvaRosana R M Corrêa
Sep 26, 2012·The Journal of Experimental Medicine·Daniel Hirschhorn-CymermanJedd D Wolchok
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mario Sznol, Lieping Chen
Apr 30, 2013·Journal of Leukocyte Biology·Andrew M Intlekofer, Craig B Thompson
Apr 15, 2017·Frontiers in Immunology·Lena MüllerDagmar Stoiber
Feb 22, 2017·Frontiers in Immunology·Lothar C DieterichMichael Detmar
Mar 21, 2017·Clinical Oral Investigations·Mathias FiedlerTobias Ettl
Dec 19, 2018·Frontiers in Immunology·Martin J RafteryGünther Schönrich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.